• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Leber 先天性黑矇与基因治疗。

Leber's Congenital Amaurosis and Gene Therapy.

机构信息

Retina and Uvea Services, Dr R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India.

出版信息

Indian J Pediatr. 2018 Mar;85(3):237-242. doi: 10.1007/s12098-017-2394-1. Epub 2017 Jul 7.

DOI:10.1007/s12098-017-2394-1
PMID:28685406
Abstract

Retinal blindness is an important cause of pediatric visual loss. Leber's congenital amaurosis (LCA) is one of these causes, often wrongly included in the spectrum of retinitis pigmentosa. The disease has become the center of research after initial reports of success in management with gene therapy. This review discusses in brief the clinical presentation and investigative modalities used in LCA. Further, the road to gene discovery and details of currently applied gene therapy are presented. LCA is one of the first successfully managed human diseases and offers an entirely new dimension in ocular therapeutics.

摘要

视网膜盲是儿童视力丧失的一个重要原因。莱伯先天性黑矇(LCA)就是其中一个原因,它常被错误地归入视网膜色素变性的范畴。在最初的基因治疗管理成功报告之后,该疾病已成为研究的焦点。本文简要讨论了 LCA 的临床表现和所使用的检查方法。此外,还介绍了基因发现的途径和目前应用的基因治疗的细节。LCA 是第一个成功管理的人类疾病之一,为眼科学治疗提供了全新的维度。

相似文献

1
Leber's Congenital Amaurosis and Gene Therapy.Leber 先天性黑矇与基因治疗。
Indian J Pediatr. 2018 Mar;85(3):237-242. doi: 10.1007/s12098-017-2394-1. Epub 2017 Jul 7.
2
Leber congenital amaurosis: Current genetic basis, scope for genetic testing and personalized medicine.Leber 先天性黑矇:当前的遗传基础、基因检测范围和个性化医疗。
Exp Eye Res. 2019 Dec;189:107834. doi: 10.1016/j.exer.2019.107834. Epub 2019 Oct 19.
3
Leber's Congenital Amaurosis: Current Concepts of Genotype-Phenotype Correlations.Leber 先天性黑矇:基因型-表型相关性的当前概念。
Genes (Basel). 2021 Aug 19;12(8):1261. doi: 10.3390/genes12081261.
4
Gene therapy for eye as regenerative medicine? Lessons from RPE65 gene therapy for Leber's Congenital Amaurosis.作为再生医学的眼部基因治疗?来自RPE65基因治疗莱伯先天性黑蒙的经验教训。
Int J Biochem Cell Biol. 2014 Nov;56:153-7. doi: 10.1016/j.biocel.2014.09.022. Epub 2014 Oct 5.
5
Follow-up and diagnostic reappraisal of 75 patients with Leber's congenital amaurosis.75例莱伯先天性黑矇患者的随访及诊断重新评估
Am J Ophthalmol. 1989 Jun 15;107(6):624-31. doi: 10.1016/0002-9394(89)90259-6.
6
Plasticity of the human visual system after retinal gene therapy in patients with Leber's congenital amaurosis.莱伯先天性黑矇患者视网膜基因治疗后人类视觉系统的可塑性
Sci Transl Med. 2015 Jul 15;7(296):296ra110. doi: 10.1126/scitranslmed.aaa8791.
7
Available Evidence on Leber Congenital Amaurosis and Gene Therapy.关于莱伯先天性黑蒙和基因治疗的现有证据。
Semin Ophthalmol. 2017;32(1):14-21. doi: 10.1080/08820538.2016.1228383. Epub 2016 Sep 29.
8
Targeted next generation sequencing identified novel mutations in RPGRIP1 associated with both retinitis pigmentosa and Leber's congenital amaurosis in unrelated Chinese patients.靶向二代测序在无关的中国患者中发现了RPGRIP1的新突变,这些突变与色素性视网膜炎和莱伯先天性黑矇均相关。
Oncotarget. 2017 May 23;8(21):35176-35183. doi: 10.18632/oncotarget.17052.
9
The effect of human gene therapy for RPE65-associated Leber's congenital amaurosis on visual function: a systematic review and meta-analysis.人 RPE65 相关莱伯先天性黑矇基因治疗对视功能的影响:系统评价和荟萃分析。
Orphanet J Rare Dis. 2020 Feb 14;15(1):49. doi: 10.1186/s13023-020-1304-1.
10
Mouse Models as Tools to Identify Genetic Pathways for Retinal Degeneration, as Exemplified by Leber's Congenital Amaurosis.以莱伯先天性黑蒙为例,小鼠模型作为鉴定视网膜变性遗传途径的工具
Methods Mol Biol. 2016;1438:417-30. doi: 10.1007/978-1-4939-3661-8_21.

引用本文的文献

1
State of the Art on Inherited Retinal Dystrophies: Management and Molecular Genetics.遗传性视网膜营养不良的现状:管理与分子遗传学
J Clin Med. 2025 May 18;14(10):3526. doi: 10.3390/jcm14103526.
2
Stimulus-Responsive Nanodelivery and Release Systems for Cancer Gene Therapy: Efficacy Improvement Strategies.刺激响应型纳米递药和释放系统用于癌症基因治疗:疗效改善策略。
Int J Nanomedicine. 2024 Jul 12;19:7099-7121. doi: 10.2147/IJN.S470637. eCollection 2024.
3
Clinical profile and demographic distribution of Stargardt disease phenotypes: An Electronic medical record-driven big data analytics from a multitier eye care network.

本文引用的文献

1
Correlation of ultra-widefield fundus autofluorescence patterns with the underlying genotype in retinal dystrophies and retinitis pigmentosa.视网膜营养不良和色素性视网膜炎中超广域眼底自发荧光模式与潜在基因型的相关性。
Ophthalmic Genet. 2017 Jul-Aug;38(4):320-324. doi: 10.1080/13816810.2016.1227450. Epub 2016 Nov 23.
2
Available Evidence on Leber Congenital Amaurosis and Gene Therapy.关于莱伯先天性黑蒙和基因治疗的现有证据。
Semin Ophthalmol. 2017;32(1):14-21. doi: 10.1080/08820538.2016.1228383. Epub 2016 Sep 29.
3
Comprehensive analysis of genetic variations in strictly-defined Leber congenital amaurosis with whole-exome sequencing in Chinese.
Stargardt 病表型的临床特征和人口统计学分布:来自多层次眼科保健网络的电子病历驱动的大数据分析。
Indian J Ophthalmol. 2023 Oct;71(10):3407-3411. doi: 10.4103/IJO.IJO_3290_22.
4
Oculodigital Sign: A Clinical Clue for Diagnosis.眼指征:诊断的临床线索
Ann Indian Acad Neurol. 2022 May-Jun;25(3):560-561. doi: 10.4103/aian.aian_755_21. Epub 2022 May 3.
5
Associations Between Fundus Types and Clinical Manifestations in Patients with RDH12 Gene Mutations.RDH12 基因突变患者眼底类型与临床表现的相关性研究。
Brain Topogr. 2022 Jul;35(4):525-535. doi: 10.1007/s10548-021-00885-7. Epub 2022 Jan 10.
6
Voretigene Neparvovec and Gene Therapy for Leber's Congenital Amaurosis: Review of Evidence to Date.沃瑞替尼帕维韦克与莱伯先天性黑蒙的基因治疗:迄今证据综述
Appl Clin Genet. 2020 Nov 25;13:179-208. doi: 10.2147/TACG.S230720. eCollection 2020.
7
Lutein and Zeaxanthin Isomers Reduce Photoreceptor Degeneration in the Mouse Model of Retinitis Pigmentosa.叶黄素和玉米黄质异构体可减少 色素性视网膜炎 小鼠模型中的光感受器变性。
Biomed Res Int. 2018 Dec 17;2018:4374087. doi: 10.1155/2018/4374087. eCollection 2018.
8
Retinal detachment in a child with severe early childhood onset retinal dystrophy.一名患有严重早发性视网膜营养不良的儿童发生视网膜脱离。
BMJ Case Rep. 2018 Aug 27;2018:bcr-2018-227073. doi: 10.1136/bcr-2018-227073.
9
Editorial: Pediatric Ophthalmology - Part II.社论:小儿眼科——第二部分。
Indian J Pediatr. 2018 Mar;85(3):207-208. doi: 10.1007/s12098-018-2619-y. Epub 2018 Feb 9.
在中国通过全外显子组测序对严格定义的莱伯先天性黑矇的基因变异进行综合分析。
Int J Ophthalmol. 2016 Sep 18;9(9):1260-4. doi: 10.18240/ijo.2016.09.04. eCollection 2016.
4
Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65.针对因RPE65缺陷导致的莱伯先天性黑蒙症,开发一种优化的AAV2/5基因治疗载体。
Gene Ther. 2016 Dec;23(12):857-862. doi: 10.1038/gt.2016.66. Epub 2016 Sep 22.
5
Targeting iodothyronine deiodinases locally in the retina is a therapeutic strategy for retinal degeneration.在视网膜局部靶向碘甲状腺原氨酸脱碘酶是一种治疗视网膜变性的策略。
FASEB J. 2016 Dec;30(12):4313-4325. doi: 10.1096/fj.201600715R. Epub 2016 Sep 13.
6
Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial.RPE65基因突变所致儿童期失明患者对侧眼给予AAV2基因治疗的安全性及疗效持久性:一项1期随访试验
Lancet. 2016 Aug 13;388(10045):661-72. doi: 10.1016/S0140-6736(16)30371-3. Epub 2016 Jun 30.
7
[Gene therapy for hereditary ophthalmological diseases: Advances and future perspectives].[遗传性眼科疾病的基因治疗:进展与未来展望]
Gac Med Mex. 2015 Jul-Aug;151(4):501-11.
8
Long-term effect of gene therapy on Leber's congenital amaurosis.基因治疗对莱伯先天性黑蒙的长期影响。
N Engl J Med. 2015 May 14;372(20):1887-97. doi: 10.1056/NEJMoa1414221. Epub 2015 May 4.
9
Review and update on the molecular basis of Leber congenital amaurosis.莱伯先天性黑矇分子基础的综述与更新
World J Clin Cases. 2015 Feb 16;3(2):112-24. doi: 10.12998/wjcc.v3.i2.112.
10
Autosomal-dominant Leber Congenital Amaurosis Caused by a Heterozygous CRX Mutation in a Father and Son.父子中由杂合CRX突变引起的常染色体显性遗传性莱伯先天性黑蒙症
Ophthalmic Genet. 2015 Jun;36(2):156-9. doi: 10.3109/13816810.2013.838273. Epub 2013 Oct 4.